Extension of Time to File SOU

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1581

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

SOU Extension Request
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:

MARK: SAMIVIR (see, http://uspto.report/TM/90087709/mark.png)
SERIAL NUMBER: 90087709

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Neurorx, Inc., having an address of
      1201 North Market Street, Suite 111
      Wilmington, Delaware 19801
      United States
      Phone: 202-340-1352
      Email: XXXX
Proposed: Neurorx, Inc., having an address of
      1201 North Market Street, Suite 111
      Wilmington, Delaware 19801
      United States
      Phone: 202-340-1352
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 02/23/2021.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development ; market research ; manufacturing activities ; steps to acquire distributors ; steps to obtain required governmental approval

Correspondence Information (current):
      Brian J. Del Buono
      PRIMARY EMAIL FOR CORRESPONDENCE: bdelbuono@nrxpharma.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jjavitt@neurorxpharma.com; adaigneault@nrxpharma.com; mkunz@nrxpharma.com

Correspondence Information (proposed):
      Brian J. Del Buono
      PRIMARY EMAIL FOR CORRESPONDENCE: bdelbuono@nrxpharma.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jjavitt@neurorxpharma.com; adaigneault@nrxpharma.com; mkunz@nrxpharma.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Brian J. Del Buono/      Date Signed: 02/22/2022
Signatory's Name: Brian J. Del Buono
Signatory's Position: Attorney of Record, Virginia Bar member
Signatory's Phone: 17034025866
Signature method: Signed directly within the form

PAYMENT: 90087709
PAYMENT DATE: 02/22/2022

Serial Number: 90087709
Internet Transmission Date: Tue Feb 22 13:34:54 ET 2022
TEAS Stamp: USPTO/ESU-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20220222133454706701-90087709-
8004b1d86c1addea1d0ede2685125cb4e37b3e32
934f580d71f365af0dddd2fbff-CC-34510014-2
0220222133039249150